.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Doobie Labs is stocked at 185 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Staten Island, and The Bronx. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Doobie Labs concentrated 74.31% share in Flower with year-over-year growth of 36.70% but a month-over-month decline of 8.12%, while Pre-Roll rose to 18.70% share with 105.39% year-over-year growth and a 3.57% month-over-month decline; Vapor Pens held 7.00% share with a 34.89% month-over-month decline and no year-over-year baseline. The brand’s average price fell 15.60% year over year to $39.78 even as total brand sales grew 57.58% year over year, suggesting volume-led gains concentrated in Flower and Pre-Roll despite sequential softness; this mix, paired with a rank of 26 in Flower in New York, implies the growth engine is weighted to value-accessible formats rather than premium-priced line extensions.
The shift toward Pre-Roll gaining share from 18.70% alongside Flower’s 74.31% and Vapor Pens’ 7.00% signals a tilt to combustion-centric occasions, with August 2026 month-over-month declines of 3.57% in Pre-Roll and 8.12% in Flower contrasting with a deeper 34.89% slide in Vapor Pens; coupled with a 15.60% average price reduction and 57.58% brand sales growth year over year, the pattern points to price elasticity driving unit throughput in core inhalables. Given a Flower category rank of 26 in New York and a category mix where non-Flower remains under 26.00% share, the implication is that near-term positioning is anchored in mid-priced Flower and value Pre-Rolls, with Vapor Pens requiring recalibration rather than near-term expansion.
Competitive Landscape
Doobie Labs sits at rank #26 in New York Flower for August 2026, improving 5 positions from rank #31 year over year, while slipping 2 spots from #24 in May 2026 and remaining 6 positions below its peak of #20 in November 2025; in contrast, Find. advanced from #6 to #1 with approximately 30.3% YoY sales growth and Grassroots climbed from #14 to #4 alongside an 88.4% YoY sales increase, indicating that competitors are converting growth into rank gains faster than Doobie Labs’ modest rank lift. The pattern implies Doobie Labs’ trajectory is stabilizing mid-pack—up year over year but down versus recent months—so sustaining rank recovery will likely require outpacing top-tier movers that are accelerating both share and placement.
Notable Products
Blue Lobster Pre-Roll (1g) posted the steepest movement in August 2026 with a -52.4% month-over-month drop while sitting at rank 3, which, alongside Blue Dream (3.5g) declining -19.6% at rank 1, signals volatility concentrated in pre-rolls versus steadier flower. Countering that, Blue Lobster (3.5g) jumped +31.8% to rank 2 and Northern Lights (3.5g) added +8.2% at rank 5, while four of the top ten are Flower SKUs, indicating assortment weight tilted toward flower. With Blue Lobster (3.5g) nearing Blue Dream (3.5g) in rank despite lower dollar sales at $73,451, the mix suggests Doobie Labs is pivoting toward flower-led traffic while pruning or re-pricing pre-rolls to manage margin and demand risk.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
